Publicacions - IR Sant Pau

Cercar

01/08/2021 Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis

Amaro, AB, Curco, AS, Garcia, E, Julve, J, Rives, J, Benitez, S, Cortes, VL. Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis. Journal of Clinical Medicine. 2021; 10(16)DOI:10.3390/jcm10163571. PMID:34441867. IF:4.964(Q2/4D).

01/08/2021 Apolipoprotein mimetics in cancer

Delk, SC, Chattopadhyay, A, Escola-Gil, JC, Fogelman, AM, Reddy, ST. Apolipoprotein mimetics in cancer. SEMINARS IN CANCER BIOLOGY. 2021; 73DOI:10.1016/j.semcancer.2020.11.002. PMID:33188891. IF:17.012(Q1/1D).

01/08/2021 Beneficial effects of olive oil and Mediterranean diet on cancer physio-pathology and incidence

Farras, M, Almanza-Aguilera, E, Hernaez, A, Agusti, N, Julve, J, Fito, M, Castaner, O. Beneficial effects of olive oil and Mediterranean diet on cancer physio-pathology and incidence. SEMINARS IN CANCER BIOLOGY. 2021; 73DOI:10.1016/j.semcancer.2020.11.011. PMID:33249203. IF:17.012(Q1/1D).

01/08/2021 High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future

Julve, J, Escola-Gil, JC. High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future. Biomedicines. 2021; 9(8)DOI:10.3390/biomedicines9080857. PMID:34440061. IF:4.757(Q2/4D).

01/08/2021 Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies

Papotti, B, Escola-Gil, JC, Julve, J, Poti, F, Zanotti, I. Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies. Nutrients. 2021; 13(8)DOI:10.3390/nu13082643. PMID:34444804. IF:6.706(Q1/2D).

01/08/2021 Special issue: Diet, lipids, and cancer: From Pathogenic mechanisms to potential therapeutic strategies

Farras, M, Escola-Gil, JC. Special issue: Diet, lipids, and cancer: From Pathogenic mechanisms to potential therapeutic strategies. SEMINARS IN CANCER BIOLOGY. 2021; 73DOI:10.1016/j.semcancer.2021.05.015. PMID:34015466. IF:17.012(Q1/1D).

01/07/2021 Y High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future

Julve, J, Escola-Gil, JC. Y High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(14)DOI:10.3390/ijms22147488. PMID:34299108. IF:6.208(Q1/3D).

18/01/2023 Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?

Canyelles M., Borràs C., Rotllan N., Tondo M., Escolà-Gil J.C., Blanco-Vaca F.. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(3)DOI:10.3390/ijms24031940. PMID:36768264. IF:4.900(Q1/3D).

01/10/2022 Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters: A Randomized, Double-Blind, Cross-Over, Controlled Trial

Farras, M, Swann, JR, Rowland, I, Rubio, L, Subirana, I, Catalan, U, Motilva, MJ, Sola, R, Covas, MI, Blanco-Vaca, F, Fito, M, Mayneris-Perxachs, J. Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters: A Randomized, Double-Blind, Cross-Over, Controlled Trial. Antioxidants. 2022; 11(10)DOI:10.3390/antiox11101964. PMID:36290685. IF:7.000(Q1/1D).

01/03/2022 Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

Roldan-Montero, R, Perez-Saez, JM, Cerro-Pardo, I, Oller, J, Martinez-Lopez, D, Nunez, E, Maller, SM, Gutierrez-Munoz, C, Mendez-Barbero, N, Escola-Gil, JC, Michel, JB, Mittelbrunn, M, Vazquez, J, Blanco-Colio, LM, Rabinovich, GA, Martin-Ventura, JL. Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm. Science Advances. 2022; 8(11)DOI:10.1126/sciadv.abm7322. PMID:35294231. IF:13.600(Q1/1D).

01/03/2022 High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II

Julve, J, Escola-Gil, JC. High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II. Biomedicines. 2022; 10(3)DOI:10.3390/biomedicines10030620. PMID:35327422. IF:4.700(Q1/3D).

01/03/2022 The Underlying Pathology of Atherosclerosis: Different Players

Rotllan, N. The Underlying Pathology of Atherosclerosis: Different Players. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(6)DOI:10.3390/ijms23063235. PMID:35328656. IF:5.600(Q1/3D).

01/03/2022 TMAO and Gut Microbial-Derived Metabolites TML and gamma BB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism

Canyelles, M, Plaza, M, Rotllan, N, Llobet, D, Julve, J, Mojal, S, Diaz-Ricart, M, Soria, JM, Escola-Gil, JC, Tondo, M, Blanco-Vaca, F, Souto, JC. TMAO and Gut Microbial-Derived Metabolites TML and gamma BB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism. Journal of Clinical Medicine. 2022; 11(5)DOI:10.3390/jcm11051425. PMID:35268516. IF:3.900(Q2/4D).

14/02/2022 Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View

Lee-Rueckert, M, Lappalainen, J, Kovanen, PT, Escola-Gil, JC. Lipid-Laden Macrophages and Inflammation in Atherosclerosis and Cancer: An Integrative View. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.777822. PMID:35237673. IF:3.600(Q2/5D).

01/02/2022 Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

Nunez, E, Fuster, V, Gomez-Serrano, M, Valdivielso, JM, Fernandez-Alvira, JM, Martinez-Lopez, D, Rodriguez, JM, Bonzon-Kulichenko, E, Calvo, E, Alfayate, A, Bermudez-Lopez, M, Escola-Gil, JC, Fernandez-Friera, L, Cerro-Pardo, I, Mendiguren, JM, Sanchez-Cabo, F, Sanz, J, Ordovas, JM, Blanco-Colio, LM, Garcia-Ruiz, JM, Ibanez, B, Lara-Pezzi, E, Fernandez-Ortiz, A, Martin-Ventura, JL, Vazquez, J. Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis. EBioMedicine. 2022; 76DOI:10.1016/j.ebiom.2022.103874. PMID:35152150. IF:11.100(Q1/1D).

01/01/2022 Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo

Rivas-Urbina A., Rotllan N., Santos D., Julve J., Sanchez-Quesada J.L., Escolà-Gil J.C.. Monitoring Atheroprotective Macrophage Cholesterol Efflux In Vivo. Methods In Molecular Biology. 2022; 2419DOI:10.1007/978-1-0716-1924-7_35. PMID:. IF:(Q/D).

01/01/2022 Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis

Rivas-Urbina A., Rotllan N., Santos D., Julve J., Escolà-Gil J.C., Sanchez-Quesada J.L.. Assessment of Ex Vivo Antioxidative Potential of Murine HDL in Atherosclerosis. Methods In Molecular Biology. 2022; 2419DOI:10.1007/978-1-0716-1924-7_17. PMID:. IF:(Q/D).

08/11/2021 MMAB promotes negative feedback control of cholesterol homeostasis

Goedeke, L, Canfran-Duque, A, Rotllan, N, Chaube, B, Thompson, BM, Lee, RG, Cline, GW, McDonald, JG, Shulman, GI, Lasuncion, MA, Suarez, Y, Fernandez-Hernando, C. MMAB promotes negative feedback control of cholesterol homeostasis. Nature Communications. 2021; 12(1)DOI:10.1038/s41467-021-26787-7. PMID:34750386. IF:17.694(Q1/1D).

19/09/2025 Circulating tumor DNA in patients with cancer: insights from clinical laboratory

Illana, FJ, Fernández-Galán, E, Muñoz-Bravo, JL, Amado, LV, Martín, CG, González-Fernández, C, Miró-Cañís, S, Trapé, J, Martínez-Peinado, A, Filella, X, González, A, Sánchez, AB, Díaz-Lagares, A. Circulating tumor DNA in patients with cancer: insights from clinical laboratory. ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO. 2025; 6(3)DOI:10.1515/almed-2025-0010. PMID:40977813. IF:(Q/D).

01/09/2025 Lipids and lipoproteins in the interstitial tissue fluid regulate the formation of dysfunctional tissue-resident macrophages: Implications for atherogenic, tumorigenic, and obesogenic processes

Lee-Rueckert, M, Jauhiainen, M, Kovanen, PT, Escolà-Gil, JC. Lipids and lipoproteins in the interstitial tissue fluid regulate the formation of dysfunctional tissue-resident macrophages: Implications for atherogenic, tumorigenic, and obesogenic processes. SEMINARS IN CANCER BIOLOGY. 2025; 114DOI:10.1016/j.semcancer.2025.06.008. PMID:40545184. IF:15.700(Q1/1D).

01/07/2025 Analytical Interference of Exemestane with Androstenedione Immunoassays

Giralt, M, Ferrer, R, Díaz-Troyano, N, Vega, B, Luque-Ramírez, M, Martínez, S, Fernández, B, Martínez, I, Fabregat, A, Urgell, E, Cardona, I, Casals, G, Escobar-Morreale, HF. Analytical Interference of Exemestane with Androstenedione Immunoassays. Annals of Laboratory Medicine. 2025; 45(4)DOI:10.3343/alm.2024.0362. PMID:40114653. IF:3.900(Q1/1D).

01/09/2024 Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis

Fernandez-Bravo, S, Canyelles, M, Martín-Blázquez, A, Borràs, C, Nuñez-Borque, E, Palacio-García, L, Del Rio, PR, Betancor, D, Gómez-López, A, Brescó, MS, Laguna, JJ, Méndez-Barbero, N, Rotllan, N, Escolà-Gil, JC, Esteban, V. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(3)DOI:10.1016/j.jaci.2024.03.031. PMID:38718948. IF:11.200(Q1/1D).

01/08/2024 IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT

Velasco, L, Querol, CB, Santos, D, Rotllan, N, Tondo, M, Camacho, M, Blanco-Vaca, F, Escolà-Gil, JC, Canyelles, M. IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).

01/08/2024 HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS

Grao-Cruces, E, Mocciaro, G, Marquez-Paradas, E, Santos-Mejias, A, Canyelles, M, Escola-Gil, JC, Martin-Rubio, ME, La Paz, SMD. HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).

31/07/2024 Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trial

Oliveras, A, Vázquez, S, Vega, MV, Camps, C, Illana, FJ, Armario, P, Crespo, M, de la Sierra, A. Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trial. HYPERTENSION RESEARCH. 2024; DOI:10.1038/s41440-024-01748-x. PMID:39085464. IF:4.600(Q1/2D).

01/07/2024 Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice

Delgado-Lista, J, Mostaza, JM, Arrobas-Velilla, T, Blanco-Vaca, F, Masana, L, Pedro-Botet, J, Perez-Martinez, P, Civeira, F, Cuende-Melero, JI, Gomez-Barrado, JJ, Lahoz, C, Pinto, X, Suarez-Tembra, M, Lopez-Miranda, J, Guijarro, C. Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice. Clinica E Investigacion En Arteriosclerosis. 2024; 36(4)DOI:10.1016/j.arteri.2024.03.002. PMID:38599943. IF:(Q/D).

17/06/2024 Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis

La Lhoëst, MTL, Martinez, A, Claudi, L, Garcia, E, Benitez-Amaro, A, Polishchuk, A, Piñero, J, Vilades, D, Guerra, JM, Sanz, F, Rotllan, N, Escolà-Gil, JC, Llorente-Cortés, V. Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis. Frontiers in Cardiovascular Medicine. 2024; 11DOI:10.3389/fcvm.2024.1381520. PMID:38952543. IF:2.900(Q2/4D).

01/06/2024 Apolipoproteins and Lipoproteins in Health and Disease 2.0

Rotllan, N, Escolà-Gil, JC. Apolipoproteins and Lipoproteins in Health and Disease 2.0. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(11)DOI:10.3390/ijms25116183. PMID:38892369. IF:4.900(Q1/3D).

01/06/2024 Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes

Illana, FJ, García-Osuna, A, Sospedra, M, Ferrer, R, Martínez-Brú, C, Guiñón, L. Quality assurance of add-on testing in plasma samples: stability limit for 29 biochemical analytes. Biochemia Medica. 2024; 34(2)DOI:10.11613/BM.2024.020704. PMID:38665870. IF:1.800(Q3/6D).

01/06/2024 Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia

Lhoëst, MTL, Samouillan, V, García, E, Amaro, AB, Dandurand, J, Dato, VA, Guerra, JM, Escolà-Gil, JC, Chiabrando, G, Enrich, C. Inhibitory effects of LRP1-based immunotherapy on cardiac extracellular matrix biophysical alterations induced by hypercholesterolemia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

29/05/2024 Decreased atherosclerosis and abdominal aortic aneurysm in mice deficient in polymeric immunoglobulin receptor

Pardo, IC, Botija, BP, Garcia, AG, Villanueva, LO, Folgado, IM, Raposo,, Mur, S, Robles,, Gil, JCE, Nunez, E, Sancho, D, Vazquez, J, Colio, LMB, Ramiro, A, Ventura, JLM. Decreased atherosclerosis and abdominal aortic aneurysm in mice deficient in polymeric immunoglobulin receptor. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.161. PMID:. IF:13.300(Q1/1D).

29/05/2024 Role of polymeric immunoglobulin receptor in glucose metabolism

Botija, MP, Pardo, IC, Garcia, AG, Villanueva, LO, Colio, LB, Ramiro, A, Gil, JCE, Ventura, JLM. Role of polymeric immunoglobulin receptor in glucose metabolism. CARDIOVASCULAR RESEARCH. 2024; 120DOI:10.1093/cvr/cvae088.192. PMID:. IF:13.300(Q1/1D).

01/01/2024 Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model

de las Hazas, MCL, del Saz-Lara, A, Cedó, L, Crespo, MC, Tomé-Carneiro, J, Chapado, LA, Macià, A, Visioli, F, Escola-Gil, JC, Dávalos, A. Hydroxytyrosol Induces Dyslipidemia in an ApoB100 Humanized Mouse Model. MOLECULAR NUTRITION & FOOD RESEARCH. 2024; 68(1)DOI:10.1002/mnfr.202300508. PMID:37933702. IF:4.200(Q1/3D).

14/12/2023 Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation

Martinez-Campanario, MC, Cortés, M, Moreno-Lanceta, A, Han, L, Ninfali, C, Domínguez, V, Andrés-Manzano, MJ, Farràs, M, Esteve-Codina, A, Enrich, C, Diaz-Crespo, FJ, Pintado, B, Escolà-Gil, JC, de Frutos, PG, Andrés, V, Melgar-Lesmes, P, Postigo, A. Atherosclerotic plaque development in mice is enhanced by myeloid ZEB1 downregulation. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-43896-7. PMID:38097578. IF:14.700(Q1/1D).

01/11/2023 Characterization of add-on testing before and after automation at a core laboratory

García-Osuna, A, Muñoz, LG, Pallaruelo, MC, Usero, AM, Eduardo, BC, Ramos, JL, Canyelles, M, Brú, CM, Cámara, FJI. Characterization of add-on testing before and after automation at a core laboratory. Heliyon. 2023; 9(11)DOI:10.1016/j.heliyon.2023.e22096. PMID:38034602. IF:3.400(Q1/3D).

27/10/2023 Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine

Hueso, M, Rotllan, N, Escolà-Gil, JC, Vellido, A. Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine. Frontiers in Cardiovascular Medicine. 2023; 10DOI:10.3389/fcvm.2023.1320110. PMID:37965080. IF:2.800(Q2/4D).

12/10/2023 Periodic verification of results' comparability between several analyzers: Experience in the application of the EP31-A-IR guideline

Guiñón L., Illana F.J., Cuevas B., Canyelles M., Martínez-Bru C., García-Osuna Á.. Periodic verification of results' comparability between several analyzers: Experience in the application of the EP31-A-IR guideline. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 62(3)DOI:10.1515/cclm-2023-0994. PMID:37819627. IF:3.800(Q1/2D).

01/08/2023 Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism

Lee-Rueckert, M, Canyelles, M, Tondo, M, Rotllan, N, Kovanen, PT, Llorente-Cortes, V, Escola-Gil, JC. Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism. SEMINARS IN CANCER BIOLOGY. 2023; 93DOI:10.1016/j.semcancer.2023.05.002. PMID:37156344. IF:12.100(Q1/1D).

01/06/2023 "MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression"

Frutos, MFD, Pardo-Marques, V, Torrecilla-Parra, M, Rada, P, Perez-Garcia, A, Martin-Martin, Y, de la Pena, G, Gomez, A, Toledano-Zaragoza, A, Gomez-Coronado, D, Casarejos, MJ, Solis, JM, Rotllan, N, Pastor, O, Ledesma, MD, Valverde, AM, Busto, R, Ramirez, CM. "MiR-7 controls cholesterol biosynthesis through posttranscriptional regulation of DHCR24 expression". Biochimica et Biophysica Acta-Gene Regulatory Mechanisms. 2023; 1866(2)DOI:10.1016/j.bbagrm.2023.194938. PMID:37086967. IF:2.600(Q3/6D).

11/05/2023 Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia

Samouillan, V, Garcia, E, Benitez-Amaro, A, Lhoest, MTLC, Dandurand, J, Dato, VA, Guerra, JM, Escola-Gil, JC, Chiabrando, G, Enrich, C, Llorente-Cortes, V. Inhibitory Effects of LRP1-Based Immunotherapy on Cardiac Extracellular Matrix Biophysical Alterations Induced by Hypercholesterolemia. JOURNAL OF MEDICINAL CHEMISTRY. 2023; 66(9)DOI:10.1021/acs.jmedchem.2c02103. PMID:37116069. IF:6.900(Q1/1D).

01/05/2023 Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

Soler-Vazquez, MC, Romero, MD, Todorcevic, M, Delgado, K, Calatayud, C, Benitez-Amaro, A, Lhoest, MTL, Mera, P, Zagmutt, S, Bastias-Perez, M, Ibeas, K, Casals, N, Escola-Gil, JC, Llorente-Cortes, V, Consiglio, A, Serra, D, Herrero, L. Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice. METABOLIC ENGINEERING. 2023; 77DOI:10.1016/j.ymben.2023.04.010. PMID:37088334. IF:6.800(Q1/1D).

04/04/2023 SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression

Villanueva-Carmona, T, Cedo, L, Madeira, A, Ceperuelo-Mallafre, V, Rodriguez-Pena, MM, Nunez-Roa, C, Maymo-Masip, E, Repolles-de-Dalmau, M, Badia, J, Keiran, N, Mirasierra, M, Pimenta-Lopes, C, Sabadell-Basallote, J, Bosch, R, Caubet, L, Escola-Gil, JC, Fernandez-Real, JM, Vilarrasa, N, Ventura, F, Vallejo, M, Vendrell, J, Fernandez-Veledo, S. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression. Cell Metabolism. 2023; 35(4)DOI:10.1016/j.cmet.2023.03.004. PMID:36977414. IF:27.700(Q1/1D).

01/01/2023 Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor

Ferrer R., Mansilla A., Tondo M., Blanco-Vaca F.. Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor. Journal Of Laboratory And Precision Medicine. 2023; 8DOI:10.21037/jlpm-22-70. PMID:. IF:(Q/D).

01/01/2022 MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses

Martos-Folgado I., del Monte-Monge A., Lorenzo C., Busse C.E., Delgado P., Mur S.M., Cobos-Figueroa L., Escolà-Gil J.C., Martín-Ventura J.L., Wardemann H., Ramiro A.R.. MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses. Cell Reports. 2022; 41(2)DOI:10.1016/j.celrep.2022.111468. PMID:36223741. IF:8.800(Q1/2D).

06/05/2022 Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression

Simoes, AM, Holmstrom, MO, Aehnlich, P, Rahbech, A, Radziwon-Balicka, A, Zamora, C, Klausen, TW, Skov, V, Kjaer, L, Ellervik, C, El Fassi, D, Vidal, S, Hasselbalch, HC, Andersen, MH, Straten, PT. Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.866610. PMID:35603202. IF:7.300(Q1/3D).

01/12/2021 Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease

Isola, I, Moreno, DF, Moga, E, Mena, MP, Tovar, N, Rodriguez-Lobato, LG, Oliver-Caldes, A, Salgado, MC, Braso-Maristany, F, Yague, J, Cibeira, MT, Prat, A, Rosinol, L, Blade, J, de Larrea, CF. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. ANNALS OF HEMATOLOGY. 2021; 100(12)DOI:10.1007/s00277-021-04653-2. PMID:34463804. IF:4.030(Q2/5D).

01/12/2021 Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review

d'Alessandro, M, Bergantini, L, Bargagli, E, Vidal, S. Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review. Life-Basel. 2021; 11(12)DOI:10.3390/life11121401. PMID:34947932. IF:3.253(Q2/5D).

07/09/2021 The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome (vol 7, 12288, 2021)

Vidal, S, Brandi, N, Pacheco, P, Gerotina, E, Blasco, L, Trotta, JR, Derdak, S, O'Callaghan, MD, Garcia-Cazorla, A, Pineda, M, Armstrong, J, Cortes, R., Gallano P., Villar, Cristina. The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome (vol 7, 12288, 2021). Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-97262-y. PMID:34493777. IF:4.997(Q2/3D).

10/09/2025 Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline

Park, HS, del Campo, PD, Plana, MN, La Borda, JPY, Guerra-Rodriguez, M, Moreno, M, Cañete, JD. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1621313. PMID:41001393. IF:3.000(Q1/2D).

18/06/2025 Laboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey

Aguado, R, Irure-Ventura, J, Vargas, ML, Roy, G, Barrios, Y, Martínez-Martínez, L, Rodríguez, B, Montes-Cano, MA, López-Hoyos, M, Jurado, A. Laboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey. Nutrients. 2025; 17(12)DOI:10.3390/nu17122032. PMID:40573143. IF:5.000(Q1/2D).

01/06/2025 RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM

Ruiz-Esquide, V, Roig-Vilaseca, D, Mateo-Soria, L, Pérez, SH, Nack, A, Perez-Garcia, C, Park, HS, Paños, HB, Gómez-Puerta, JA, Sanmarti, R. RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2454. PMID:. IF:20.600(Q1/1D).

01/10/2024 OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY

Buddingh, EP, Slatter, M, Becerra, JCA, Garcia, LA, von Asmuth, E, Baris, S, de la Calle-Mart n, O, Chan, A, Chan, B, Chandrakasan, S, Chellapandian, D, Dara, J, Landsverk, HCE, Farmand, S, Fasth, A, Forbes, L, Formankova, R, Grunebaum, E, Keogh, S, Kiykim, A, K hl, JS, Laberko, A, Lankester, A, Leahy, TR, Lindemans, C, Martinez, C, Mart nez-Mart nez, L, Mitchell, WG, Morris, E, Neven, B, Oved, J, Prazenicova, M, Riviere, JG, Roifman, C, G ltekin, SSK, Sedlacek, P, Shah, A, Vong, L, Leiding, J, Sch tz, C. OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).

01/09/2024 Serum calprotectin in severe and mild COVID-19 patients

Agulló, GJ, Aragon, MP, de la Poza, JFD, Alcorisa, SV. Serum calprotectin in severe and mild COVID-19 patients. EUROPEAN JOURNAL OF IMMUNOLOGY. 2024; 54DOI:. PMID:. IF:3.700(Q2/5D).

12/01/2024 Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells

Staniek, J, Kalina, T, Andrieux, G, Boerries, M, Janowska, I, Fuentes, M, Diez, P, Bakardjieva, M, Stancikova, J, Raabe, J, Neumann, J, Schwenk, S, Arpesella, L, Stuchly, J, Benes, V, Valiente, RG, Garcia, JF, Carsetti, R, Mortari, EP, Catala, A, de la Calle, O, Sogkas, G, Neven, B, Rieux-Laucat, F, Magerus, A, Neth, O, Olbrich, P, Voll, RE, Alsina, L, Allende, LM, Gonzalez-Granado, LI, Boehler, C, Thiel, J, Venhoff, N, Lorenzetti, R, Warnatz, K, Unger, S, Seidl, M, Mielenz, D, Schneider, P, Ehl, S, Rensing-Ehl, A, Smulski, CR, Rizzi, M. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells. Science Immunology. 2024; 9(91)DOI:10.1126/sciimmunol.adj5948. PMID:38215192. IF:16.300(Q1/1D).

01/10/2023 Inherited human ezrin deficiency impairs adaptive immunity

García-Solís B., Van Den Rym A., Martinez-Martínez L., Franco T., Pérez-Caraballo J.J., Markle J., Cubillos-Zapata C., Marín A.V., Recio M.J., Regueiro J.R., Navarro-Zapata A., Mestre-Durán C., Ferreras C., Martín Cotázar C., Mena R., de la Calle-Fabregat C., López-Lera A., Fernández Arquero M., Pérez-Martínez A., López-Collazo E., Sánchez-Ramón S., Casanova J.-L., Martínez-Barricarte R., de la Calle-Martín O., Pérez de Diego R.. Inherited human ezrin deficiency impairs adaptive immunity. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2023; 152(4)DOI:10.1016/j.jaci.2023.05.022. PMID:37301410. IF:11.400(Q1/1D).

17/05/2023 Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey

Martinez-Martinez, L, Irure-Ventura, J, Jurado, A, Roy, G, Montes, MA, Barrios, Y, Rodriguez-Bayona, B, Vergara, E, Prada, A, Rojo, R, Vargas, ML. Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey. IMMUNOLOGIC RESEARCH. 2023; 71(5)DOI:10.1007/s12026-023-09389-x. PMID:37195550. IF:3.300(Q3/6D).

19/04/2023 Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated bla(IMI-6) Gene

Blanco-Martin, T, Guzman-Puche, J, Riazzo, C, Gasca-Santiyan, M, Hernandez-Garcia, M, Canton, R, Torre-Cisneros, J, Herrera, C, Martinez-Martinez, L. Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated bla(IMI-6) Gene. Microbiology Spectrum. 2023; 11(3)DOI:10.1128/spectrum.04620-22. PMID:37074170. IF:3.700(Q2/4D).

05/08/2022 Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression (vol 13, 866610, 2022)

Simoes, AMC, Holmstrom, MO, Aehnlich, P, Rahbech, A, Peeters, MJW, Radziwon-Balicka, A, Zamora, C, Klausen, TW, Skov, V, Kjaer, L, Ellervik, C, El Fassi, D, Vidal, S, Hasselbalch, HC, Andersen, MH, Straten, PT. Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression (vol 13, 866610, 2022). Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.970322. PMID:35990670. IF:7.300(Q1/3D).

01/11/2025 Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

Puente, A, Turón, F, Martínez, J, Fortea, JI, Guerra, MH, Alvarado, E, Pons, M, Magaz, M, Llop, E, Alvarez-Navascués, C, Navarrete, AA, Berenguer, M, Masnou, H, Bañares, R, Casado, M, Ampuero, J, Rios, J, Saavedra, C, Blasi, A, Lisman, T, Figuero, CR, Huelin, P, Tellez, L, Arráez, DM, Rodriguez, M, Aguilera, V, Loste, MTA, Baiges, A, Hernandez-Gea, V, Perelló, C, Calleja, JL, Genescà, J, Villanueva, C, Gonzalez-Alayón, C, Albillos, A, Crespo, J, Garcia-Pagán, JC. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study. JOURNAL OF HEPATOLOGY. 2025; 83(5)DOI:10.1016/j.jhep.2025.06.035. PMID:40691992. IF:33.000(Q1/1D).

06/02/2025 DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders

Lessel, I, Baresic, A, Chinn, IK, May, J, Goenka, A, Chandler, KE, Posey, JE, Afenjar, A, Averdunk, L, Bedeschi, MF, Besnard, T, Brager, R, Brick, L, Brugger, M, Brunet, T, Byrne, S, de la Calle-Martín, O, Capra, V, Cardenas, P, Chappé, C, Chong, HJ, Cogne, B, Conboy, E, Cope, H, Courtin, T, Deb, W, Dilena, R, Dubourg, C, Elgizouli, M, Fernandes, E, Fitzgerald, KK, Gangi, S, George-Abraham, JK, Gucsavas-Calikoglu, M, Haack, TB, Hadonou, M, Hanker, B, Hüning, I, Iascone, M, Isidor, B, Järvelä, I, Jin, JJ, Jorge, AAL, Josifova, D, Kalinauskiene, R, Kamsteeg, EJ, Keren, B, Kessler, E, Kölbel, H, Kozenko, M, Kubisch, C, Kuechler, A, Leal, SM, Leppälä, J, Luu, SM, Lyon, GJ, Madan-Khetarpal, S, Mancardi, M, Marchi, E, Mehta, L, Menendez, B, Morel, CF, Harasink, SM, Nevay, DL, Nigro, V, Odent, S, Oegema, R, Pappas, J, Pastore, MT, Perilla-Young, Y, Platzer, K, Powell-Hamilton, N, Rabin, R, Rekab, A, Rezende, RC, Robert, L, Romano, F, Scala, M, Poths, K, Schrauwen, I, Sebastian, J, Short, J, Sidlow, R, Sullivan, J, Szakszon, K, Tan, QKG, Wagner, M, Wieczorek, D, Yuan, B, Maeding, N, Strunk, D, Begtrup, A, Banka, S, Lupski, JR, Tolosa, E, Lessel, D. DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders. AMERICAN JOURNAL OF HUMAN GENETICS. 2025; 112(2)DOI:10.1016/j.ajhg.2024.12.012. PMID:39798569. IF:8.100(Q1/1D).